Key result
In middle-aged male marathoners, exercise-induced hypertension was associated with persistent angiotensin II activity and a significant reduction in total nitric oxide levels 30 minutes after maximal exercise compared to normotensive runners.
Why the study?
Data on the association between exercise-induced hypertension and angiotensin II in well-trained middle-aged marathoners were lacking.
Are angiotensin II and nitric oxide levels associated with exercise-induced hypertension in middle-aged marathoners?
Observational (n=70)
Are angiotensin II and nitric oxide levels associated with exercise-induced hypertension in middle-aged marathoners?
Exercise-induced hypertension in middle-aged marathoners is associated with sustained angiotensin II activity and reduced nitric oxide levels post-exercise, suggesting a potential pathophysiological mechanism and therapeutic target.
Angiotensin II mediates exercise-induced hypertension (EIH), which adversely impacts future cardiovascular health. There is paucity of data on the association between EIH and angiotensin II in well-trained middle-aged marathoners. Therefore, we investigated the renin-angiotensin-aldosterone-system and total nitric oxide activity in middle-aged marathoners with EIH.Seventy middle-aged marathoners were divided into 3 groups: normal blood pressure ([NBPG] [n = 21]), EIH group ([EIHG] [n = 35]), and complex hypertension group ([CHG] [n = 14]). We defined NBPG as resting systolic BP/diastolic BP (SBP/DBP) of ≤140/90 mm Hg and maximal exercise SBP of ≤210 mm Hg, EIHG as resting SBP/DBP ≤140/90 mm Hg and maximal exercise SBP of ≥210 mm Hg, and CHG as resting SBP/DBP ≥140/90 mm Hg and maximal exercise SBP of ≥210 mm Hg. Renin-angiotensin-aldosterone-system and NO levels were measured before and 30 minutes after the graded exercise test.Renin level was elevated while angiotensin level was reduced after 30 minutes of graded exercise test. There was no change in angiotensin I and angiotensin converting enzyme levels. Comparing the groups, renin level was only elevated in the CHG during recovery, while aldosterone level was higher than the baseline level in the recovery phase in all groups. Angiotensin I level remained unchanged in all groups. Angiotensin II level reduced significantly in the NBPG group but remained at the baseline in the EIHG and CHG groups. NO level was unchanged in the NBPG group but reduced in the EIHG and CHG groups after exercise. At 3 minutes of recovery, SBP was the highest in the NBPG group, followed by the EIHG and CHG groups (P < .05).In conclusion, angiotensin II activity and reduced NO level are associated with EIH in middle-aged long-distance runners. Angiotensin II inhibitors may; therefore, be the more appropriate antihypertensive medication for runners with EIH.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted an observational in Exercise-induced hypertension (n=70). Exercise-induced hypertension vs. Normal blood pressure was evaluated on Change in Angiotensin II level (ng/mL) from baseline to 30 minutes post-exercise (p=<0.05). In middle-aged male marathoners, exercise-induced hypertension was associated with persistent angiotensin II activity and a significant reduction in total nitric oxide levels 30 minutes after maximal exercise compared to normotensive runners.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: